- Home
- BNZI vs PRPO Comparison
BNZI vs PRPO Comparison
Compare BNZI & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- PRPO
- Stock Information
- Founded
- BNZI 2016
- PRPO N/A
- Country
- BNZI United States
- PRPO United States
- Employees
- BNZI N/A
- PRPO N/A
- Industry
- BNZI
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- BNZI
- PRPO Industrials
- Exchange
- BNZI Nasdaq
- PRPO Nasdaq
- Market Cap
- BNZI 8.9M
- PRPO 9.9M
- IPO Year
- BNZI N/A
- PRPO N/A
- Fundamental
- Price
- BNZI $1.64
- PRPO $6.61
- Analyst Decision
- BNZI Strong Buy
- PRPO
- Analyst Count
- BNZI 1
- PRPO 0
- Target Price
- BNZI $125.00
- PRPO N/A
- AVG Volume (30 Days)
- BNZI 4.5M
- PRPO 8.1K
- Earning Date
- BNZI 02-28-2025
- PRPO 03-28-2025
- Dividend Yield
- BNZI N/A
- PRPO N/A
- EPS Growth
- BNZI N/A
- PRPO N/A
- EPS
- BNZI N/A
- PRPO N/A
- Revenue
- BNZI $4,310,782.00
- PRPO $17,411,000.00
- Revenue This Year
- BNZI $5.58
- PRPO $75.18
- Revenue Next Year
- BNZI $58.87
- PRPO N/A
- P/E Ratio
- BNZI N/A
- PRPO N/A
- Revenue Growth
- BNZI N/A
- PRPO 31.31
- 52 Week Low
- BNZI $1.21
- PRPO $4.31
- 52 Week High
- BNZI $80.00
- PRPO $7.25
- Technical
- Relative Strength Index (RSI)
- BNZI 53.10
- PRPO 61.42
- Support Level
- BNZI $1.57
- PRPO $6.30
- Resistance Level
- BNZI $2.70
- PRPO $6.90
- Average True Range (ATR)
- BNZI 0.26
- PRPO 0.25
- MACD
- BNZI 0.05
- PRPO 0.03
- Stochastic Oscillator
- BNZI 37.58
- PRPO 83.33
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.